iOnctura BV raised £68 million (EUR 80 million) in a Series B funding round led by Syncona
Amount Raised
£68 Million
Round Type
Series B
GenevaBiotechnologyHealth CareTherapeuticsInvestors
Description
iOnctura BV, a clinical-stage biotech firm, raised £68 million (EUR 80 million) in a Series B funding round led by new investor Syncona. The funding will be utilized to expedite the development of roginolisib for treating uveal melanoma and to further develop iOnctura's pipeline asset, IOA-289 (cambritaxestat).
Quick answer
iOnctura BV raised £68 Million in a Series B round, dated June 20, 2024. Investors: 3 B Future Health Fund, Vi Partners, Inkef Capital, M Ventures, European Innovation Council Fund and Syncona. iOnctura BV is based in Geneva, Geneva, Switzerland.
- How much did iOnctura BV raise?
- iOnctura BV raised £68 Million in a Series B round on June 20, 2024.
- Who invested in iOnctura BV?
- 3 B Future Health Fund, Vi Partners, Inkef Capital, M Ventures, European Innovation Council Fund and Syncona are named as investors in this round.
- What does iOnctura BV do?
- iOnctura is a clinical-stage biopharmaceutical company combating neglected and hard-to-treat cancers with precision oral small molecules that target cancers in novel ways.
- Where is iOnctura BV based and how big is it?
- iOnctura BV is based in Geneva, Geneva, Switzerland. Fundz records about 24 employees.
- Who are the decision-makers at iOnctura BV?
- Fundz holds 1 contact at iOnctura BV. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as iOnctura BV that raised within 45 days of this round, from Fundz verified event records.
- Lapix Therapeutics raised $2.2M on August 2, 2024.
- bioAffinity Technologies raised $1.3M on August 2, 2024.
- Healx raised $47M (Series C) on August 1, 2024.
- Lipella Pharmaceuticals raised $120K on July 31, 2024.
- Convergent Therapeutics raised $22M on July 31, 2024.
- Chemomab Therapeutics Ltd raised $10M on July 29, 2024.
Who to call at iOnctura BV, and when
A new round usually means iOnctura BV is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day iOnctura BV raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at iOnctura BV, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at iOnctura BV. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment iOnctura BV raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansiOnctura BV raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.